K234068

Substantially Equivalent

ART-Plan (v.2.2.0)

Applicant: Therapanacea Sas
Product code: MUJ
Advisory panel: Radiology
Date received: 2023-12-22
Decision date: 2024-04-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Paris, FR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.